Savi P - Search Results

1

Effect of aspirin and clopidogrel on platelet-dependent tissue factor expression in endothelial cells.

Savi P, Bernat A, Dumas A, Aït-Chek L, Herbert JM. Savi P, et al. Thromb Res. 1994 Jan 15;73(2):117-24. doi: 10.1016/0049-3848(94)90086-8. Thromb Res. 1994. PMID: 8171410

2

The antiaggregating activity of clopidogrel is not affected by N-acetyl L-cysteine.

Lalé A, Herbert JM, Savi P. Lalé A, et al. Among authors: savi p. Thromb Haemost. 2003 Nov;90(5):839-43. doi: 10.1160/TH03-01-0001. Thromb Haemost. 2003. PMID: 14597979

3

P2Y12, a new platelet ADP receptor, target of clopidogrel.

Herbert JM, Savi P. Herbert JM, et al. Among authors: savi p. Semin Vasc Med. 2003 May;3(2):113-22. doi: 10.1055/s-2003-40669. Semin Vasc Med. 2003. PMID: 15199474 Review.

4

Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis.

Savi P, Herbert JM. Savi P, et al. Semin Thromb Hemost. 2005 Apr;31(2):174-83. doi: 10.1055/s-2005-869523. Semin Thromb Hemost. 2005. PMID: 15852221 Review.

5

IL-4 inhibits LPS-, IL-1 beta- and TNF alpha-induced expression of tissue factor in endothelial cells and monocytes.

Herbert JM, Savi P, Laplace MC, Lale A. Herbert JM, et al. Among authors: savi p. FEBS Lett. 1992 Sep 21;310(1):31-3. doi: 10.1016/0014-5793(92)81139-d. FEBS Lett. 1992. PMID: 1526281 Free article.

6

The antiaggregating activity of clopidogrel is due to a metabolic activation by the hepatic cytochrome P450-1A.

Savi P, Combalbert J, Gaich C, Rouchon MC, Maffrand JP, Berger Y, Herbert JM. Savi P, et al. Thromb Haemost. 1994 Aug;72(2):313-7. Thromb Haemost. 1994. PMID: 7831671

7

Evidence for the existence of two different ADP-binding sites on rat platelets.

Savi P, Laplace MC, Herbert JM. Savi P, et al. Thromb Res. 1994 Oct 15;76(2):157-69. doi: 10.1016/0049-3848(94)90186-4. Thromb Res. 1994. PMID: 7863466

8

Malformin-A1 inhibits the binding of interleukin-1 beta (IL1 beta) and suppresses the expression of tissue factor in human endothelial cells and monocytes.

Herbert JM, Savi P, Lalé A, Laplace MC, Baudry N, Pereillo JM, Emonds-Alt X. Herbert JM, et al. Among authors: savi p. Biochem Pharmacol. 1994 Sep 15;48(6):1211-7. doi: 10.1016/0006-2952(94)90158-9. Biochem Pharmacol. 1994. PMID: 7945414

9

IL-4 and IL-13 exhibit comparable abilities to reduce pyrogen-induced expression of procoagulant activity in endothelial cells and monocytes.

Herbert JM, Savi P, Laplace MC, Lalé A, Dol F, Dumas A, Labit C, Minty A. Herbert JM, et al. Among authors: savi p. FEBS Lett. 1993 Aug 16;328(3):268-70. doi: 10.1016/0014-5793(93)80941-m. FEBS Lett. 1993. PMID: 8102337 Free article.

10

Chelerythrine, a selective protein kinase C inhibitor, counteracts pyrogen-induced expression of tissue factor without effect on thrombomodulin down-regulation in endothelial cells.

Herbert JM, Savi P, Laplace MC, Dumas A, Dol F. Herbert JM, et al. Among authors: savi p. Thromb Res. 1993 Sep 15;71(6):487-93. doi: 10.1016/0049-3848(93)90122-5. Thromb Res. 1993. PMID: 8134908

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters